• Return to Headlines

Ptc Therapeutics Up 36.3% Since SmarTrend Uptrend Call (PTCT)

By Nick Russo

SmarTrend identified an Uptrend for Ptc Therapeutics (NASDAQ:PTCT) on October 23rd, 2019 at $37.79. In approximately 3 months, Ptc Therapeutics has returned 36.26% as of today's recent price of $51.50.

Ptc Therapeutics share prices have moved between a 52-week high of $53.29 and a 52-week low of $27.53 and are now trading 87% above that low price at $51.50 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.2% while the 200-day MA has risen 0.5%.

PTC Therapeutics, Inc. provides biopharmaceutical products. The Company develops orally administered and small-molecule drugs for genetic disorders, oncology, and infectious disease. PTC Therapeutics operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Ptc Therapeutics shares.

Log in and add Ptc Therapeutics (PTCT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ptc therapeutics

Ticker(s): PTCT